Contact
Please use this form to send email to PR contact of this press release:
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
TO:
Please use this form to send email to PR contact of this press release:
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
TO: